April 14, 2025 - 11:58

Today's Sagittarius horoscope reveals promising developments in both your career and financial landscape. As the stars align favorably, this is an excellent time for you to focus on professional growth. Opportunities may arise that allow you to showcase your skills and advance in your current position. Embrace any challenges that come your way, as they may lead to significant breakthroughs.
In terms of finances, the cosmic energies suggest a period of stability and potential growth. If you've been contemplating investments or financial decisions, now is an ideal time to take calculated risks. Your intuition is heightened, guiding you toward sound choices that could enhance your financial standing.
On the personal front, relationships may also flourish during this time. Open communication with loved ones will strengthen bonds and create a supportive environment for both emotional and financial discussions. Overall, today is a day filled with possibilities for Sagittarius individuals, making it essential to stay optimistic and proactive.
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...